Long Covid presents a complex challenge for clinicians, as many patients exhibit a variety of persistent symptoms suggestive of immune dysregulation. Growing interest in immunotherapies and monoclonal antibodies highlights potential benefits for certain subsets of patients. However, evidence remains limited, necessitating caution and careful patient selection in treatment approaches.
Long Covid Journey 